Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
HP Enterprise initiated with a Buy at Jefferies » 08:13
04/20/21
04/20
08:13
04/20/21
08:13
HPE

HP Enterprise

$15.96 /

+0.02 (+0.13%)

Jefferies analyst Kyle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$15.96 /

+0.02 (+0.13%)

HPE HP Enterprise
$15.96 /

+0.02 (+0.13%)

04/08/21 Morgan Stanley
HP Enterprise price target raised to $17 from $15.50 at Morgan Stanley
03/26/21 JPMorgan
HP Enterprise price target raised to $18 from $17 at JPMorgan
03/10/21
Fly Intel: Top five analyst upgrades
03/10/21 Daiwa
HP Enterprise upgraded to Outperform from Neutral at Daiwa
HPE HP Enterprise
$15.96 /

+0.02 (+0.13%)

HPE HP Enterprise
$15.96 /

+0.02 (+0.13%)

HPE HP Enterprise
$15.96 /

+0.02 (+0.13%)

Recommendations
Mesa Air price target raised to $14 from $10 at Raymond James » 07:28
04/20/21
04/20
07:28
04/20/21
07:28
MESA

Mesa Air

$11.67 /

-0.45 (-3.71%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MESA Mesa Air
$11.67 /

-0.45 (-3.71%)

MESA Mesa Air
$11.67 /

-0.45 (-3.71%)

03/04/21
Fly Intel: Top five analyst downgrades
03/04/21 Deutsche Bank
Mesa Air downgraded to Hold after 100% rally at Deutsche Bank
03/03/21 Deutsche Bank
Mesa Air downgraded to Hold from Buy at Deutsche Bank
02/17/21
Fly Intel: Top five analyst upgrades
MESA Mesa Air
$11.67 /

-0.45 (-3.71%)

MESA Mesa Air
$11.67 /

-0.45 (-3.71%)

MESA Mesa Air
$11.67 /

-0.45 (-3.71%)

Earnings
Iridium reaffirms FY21 revenue view up 3% from $463.1M lst year » 07:05
04/20/21
04/20
07:05
04/20/21
07:05
IRDM

Iridium

$38.47 /

-2.35 (-5.76%)

The Company reiterated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRDM Iridium
$38.47 /

-2.35 (-5.76%)

IRDM Iridium
$38.47 /

-2.35 (-5.76%)

04/05/21 William Blair
William Blair upgrades Gogo, sees shares going back to $13-$16
03/03/21
Fly Intel: Top five analyst upgrades
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
IRDM Iridium
$38.47 /

-2.35 (-5.76%)

Earnings
Iridium reports Q1 EPS(4c) , consensus (5c) » 07:03
04/20/21
04/20
07:03
04/20/21
07:03
IRDM

Iridium

$38.47 /

-2.35 (-5.76%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRDM Iridium
$38.47 /

-2.35 (-5.76%)

IRDM Iridium
$38.47 /

-2.35 (-5.76%)

04/05/21 William Blair
William Blair upgrades Gogo, sees shares going back to $13-$16
03/03/21
Fly Intel: Top five analyst upgrades
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
03/03/21 Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
IRDM Iridium
$38.47 /

-2.35 (-5.76%)

Recommendations
Tradeweb Markets price target raised to $80 from $69 at Citi » 05:56
04/20/21
04/20
05:56
04/20/21
05:56
TW

Tradeweb Markets

$79.68 /

-0.07 (-0.09%)

Citi analyst Ben Herbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TW Tradeweb Markets
$79.68 /

-0.07 (-0.09%)

TW Tradeweb Markets
$79.68 /

-0.07 (-0.09%)

04/12/21 Barclays
Tradeweb Markets price target raised to $90 from $71 at Barclays
04/09/21 Deutsche Bank
Tradeweb Markets price target raised to $75 from $65 at Deutsche Bank
03/31/21 Redburn
Tradeweb Markets initiated with a Buy at Redburn
03/02/21 Morgan Stanley
Tradeweb Markets resumed with an Overweight at Morgan Stanley
TW Tradeweb Markets
$79.68 /

-0.07 (-0.09%)

  • 23
    Apr
Yesterday
Hot Stocks
Integra LifeSciences issues statement on FDA communication on ADM products » 16:19
04/19/21
04/19
16:19
04/19/21
16:19
IART

Integra LifeSciences

$72.82 /

+0.57 (+0.79%)

Integra LifeSciences…

Integra LifeSciences issued the following statement regarding the FDA safety communication on the differences in complication rates between acellular dermal matrix, or ADM, products used in implant-based breast reconstruction: "Integra LifeSciences supports the efforts of the U.S. FDA to protect women's health, including its recent safety communication on ADM products used in implant-based breast reconstruction. SurgiMend Collagen Matrix is currently cleared by the FDA for use in certain types of surgeries to reinforce tissue where weakness exists, such as plastic and reconstructive surgery, and hernia repair. Neither SurgiMend nor any other ADM (human or xenograft) is currently approved for use in breast reconstruction in the United States. It is important for patients to discuss the use of medical technologies, including SurgiMend, with their healthcare providers. Integra is committed to delivering safe and effective medical technologies and products to our customers and their patients, including securing clearance or approval for a product indicated for breast reconstruction. We work to consistently meet or exceed industry and global regulatory standards to provide quality products and technologies designed to meet the needs of our customers and their patients. We applaud the ongoing work of the various surgeon associations and patient advocacy groups in reinforcing the importance of quality patient care and promoting education, advocacy, and public awareness of various healthcare issues. Integra continues to collaborate with the clinical community to pursue solutions to advance women's health."

ShowHide Related Items >><<
IART Integra LifeSciences
$72.82 /

+0.57 (+0.79%)

IART Integra LifeSciences
$72.82 /

+0.57 (+0.79%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/19/21 Citi
Integra LifeSciences price target raised to $70 from $60 at Citi
02/18/21 Piper Sandler
Integra outlook for Acell a bit concerning, says Piper Sandler
01/29/21 Piper Sandler
Integra LifeSciences price target raised to $65 from $47 at Piper Sandler
IART Integra LifeSciences
$72.82 /

+0.57 (+0.79%)

Options
Aflac option volume 44x normal after large spread rolls position » 14:20
04/19/21
04/19
14:20
04/19/21
14:20
AFL

Aflac

$53.60 /

+0.15 (+0.28%)

Aflac option volume 44x…

Aflac option volume 44x normal after large spread rolls position. Shares of the insurance company are little changed today near $53.54 following a large spread on NYSE-Arca where the May 40/50 risk reversal traded against the August 40/57.5 risk reversal 18900x. Net premium was a debit of $3.64, or $6.8M, which opens a protective collar in August using the 25% downside and 7% upside strikes, while the May 40/50 appears to close a position opened in February in a roll from November when shares were nearly $6 below current levels.

ShowHide Related Items >><<
AFL Aflac
$53.60 /

+0.15 (+0.28%)

AFL Aflac
$53.60 /

+0.15 (+0.28%)

04/05/21 JPMorgan
Aflac price target raised to $55 from $51 at JPMorgan
03/31/21 Citi
Aflac price target raised to $46 from $40 at Citi
02/08/21 Truist
Aflac price target raised to $48 from $35 at Truist
02/05/21 RBC Capital
Aflac price target raised to $47 from $40 at RBC Capital
AFL Aflac
$53.60 /

+0.15 (+0.28%)

Hot Stocks
SS&C moves forward on acquisition of Mainstream Group » 09:05
04/19/21
04/19
09:05
04/19/21
09:05
SSNC

SS&C

$72.96 /

-0.74 (-1.00%)

SS&C announced that…

SS&C announced that the board of directors of Mainstream Group has unanimously recommended an acquisition by SS&C of 100% of the shares and outstanding equity rights in Mainstream for A$2.00 per security pursuant to a scheme of arrangement. The matching rights of Vistra Group in connection with its prior Scheme Implementation Deed have now expired and Mainstream is proceeding to terminate that agreement with Vistra Group in accordance with its terms. SS&C's Scheme Implementation Deed will then become fully operative per its terms. Mainstream is a provider of investment administration, middle office, fund accounting, superannuation administration, share registry and unit registry services to fund managers and superannuation funds, family offices and dealer groups. The company serves clients globally through its offices in Australia, Hong Kong, Singapore, Ireland, Malta, Isle of Man, the Cayman Islands and the U.S. Terms of the proposed acquisition imply an enterprise value for Mainstream of approximately A$296M or approximately $225M. The purchase is expected to close in Q3.

ShowHide Related Items >><<
SSNC SS&C
$72.96 /

-0.74 (-1.00%)

SSNC SS&C
$72.96 /

-0.74 (-1.00%)

03/15/21 Credit Suisse
SS&C assumed with an Outperform at Credit Suisse
03/01/21 Credit Suisse
SS&C reinstated with an Outperform at Credit Suisse
01/08/21 BTIG
SS&C price target raised to $85 from $72 at BTIG
01/07/21 BTIG
SS&C price target raised to $85 from $72 at BTIG
SSNC SS&C
$72.96 /

-0.74 (-1.00%)

Recommendations
Pioneer Natural price target raised to $190 from $175 at Truist » 08:34
04/19/21
04/19
08:34
04/19/21
08:34
PXD

Pioneer Natural

$148.42 /

-3.79 (-2.49%)

Truist analyst Neal…

Truist analyst Neal Dingmann raised the firm's price target on Pioneer Natural to $190 from $175 and keeps a Buy rating on the shares. The company experienced a slight hit from February weather but should still top Q1 consensus estimates, the analyst tells investors in a research note, adding that its DoublePoint acquisition also provides Pioneer with an upcoming "arsenal" to help reach its desired free cash flows and shareholder returns.

ShowHide Related Items >><<
PXD Pioneer Natural
$148.42 /

-3.79 (-2.49%)

PXD Pioneer Natural
$148.42 /

-3.79 (-2.49%)

04/15/21
Fly Intel: Top five analyst downgrades
04/15/21 Scotiabank
Scotiabank downgrades Pioneer Natural to Sector Perform amid sector shake-up
04/15/21 Scotiabank
Pioneer Natural downgraded to Sector Perform from Outperform at Scotiabank
04/08/21 Truist
Diamondback Energy price target raised to $115 from $105 at Truist
PXD Pioneer Natural
$148.42 /

-3.79 (-2.49%)

PXD Pioneer Natural
$148.42 /

-3.79 (-2.49%)

PXD Pioneer Natural
$148.42 /

-3.79 (-2.49%)

PXD Pioneer Natural
$148.42 /

-3.79 (-2.49%)

Hot Stocks
Synnex signs distribution agreement with Citrix » 08:33
04/19/21
04/19
08:33
04/19/21
08:33
SNX

Synnex

$123.93 /

+2.65 (+2.19%)

, CTXS

Citrix

$140.46 /

+1.69 (+1.22%)

Synnex (SNX) announced a…

Synnex (SNX) announced a new distribution agreement with Citrix (CTXS). Under the terms of agreement, Synnex will provide their partner community with access to Citrix digital workspace solutions. The solutions will immediately be available to partners in the U.S. and Canada through Synnex Stellr.

ShowHide Related Items >><<
SNX Synnex
$123.93 /

+2.65 (+2.19%)

CTXS Citrix
$140.46 /

+1.69 (+1.22%)

SNX Synnex
$123.93 /

+2.65 (+2.19%)

03/23/21 Barrington
Synnex price target raised to $130 from $102 at Barrington
03/23/21 Loop Capital
Synnex price target raised to $132 from $108 at Loop Capital
01/13/21 Barrington
Synnex price target raised to $102 from $90 at Barrington
01/13/21 Loop Capital
Synnex price target lowered to $108 from $170 at Loop Capital
CTXS Citrix
$140.46 /

+1.69 (+1.22%)

04/13/21 BofA
Citrix reinstated with an Underperform at BofA
03/03/21 Citi
Citrix assumed with a Buy at Citi
01/20/21 RBC Capital
Citrix price target raised to $150 from $145 at RBC Capital
01/20/21 Citi
Citrix shares remain 'attractively priced,' says Citi
SNX Synnex
$123.93 /

+2.65 (+2.19%)

CTXS Citrix
$140.46 /

+1.69 (+1.22%)

SNX Synnex
$123.93 /

+2.65 (+2.19%)

SNX Synnex
$123.93 /

+2.65 (+2.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.